These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 24249745)

  • 1. Circulating inflammation markers and prospective risk for lung cancer.
    Shiels MS; Pfeiffer RM; Hildesheim A; Engels EA; Kemp TJ; Park JH; Katki HA; Koshiol J; Shelton G; Caporaso NE; Pinto LA; Chaturvedi AK
    J Natl Cancer Inst; 2013 Dec; 105(24):1871-80. PubMed ID: 24249745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Inflammation Markers, Risk of Lung Cancer, and Utility for Risk Stratification.
    Shiels MS; Katki HA; Hildesheim A; Pfeiffer RM; Engels EA; Williams M; Kemp TJ; Caporaso NE; Pinto LA; Chaturvedi AK
    J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26220734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer.
    Pine SR; Mechanic LE; Enewold L; Chaturvedi AK; Katki HA; Zheng YL; Bowman ED; Engels EA; Caporaso NE; Harris CC
    J Natl Cancer Inst; 2011 Jul; 103(14):1112-22. PubMed ID: 21685357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cigarette smoking and variations in systemic immune and inflammation markers.
    Shiels MS; Katki HA; Freedman ND; Purdue MP; Wentzensen N; Trabert B; Kitahara CM; Furr M; Li Y; Kemp TJ; Goedert JJ; Chang CM; Engels EA; Caporaso NE; Pinto LA; Hildesheim A; Chaturvedi AK
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25274579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of immune and inflammation markers and risk of lung cancer among female never smokers in Shanghai.
    Shiels MS; Shu XO; Chaturvedi AK; Gao YT; Xiang YB; Cai Q; Hu W; Shelton G; Ji BT; Pinto LA; Kemp TJ; Rothman N; Zheng W; Hildesheim A; Lan Q
    Carcinogenesis; 2017 Oct; 38(10):1004-1010. PubMed ID: 28981818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein and risk of lung cancer.
    Chaturvedi AK; Caporaso NE; Katki HA; Wong HL; Chatterjee N; Pine SR; Chanock SJ; Goedert JJ; Engels EA
    J Clin Oncol; 2010 Jun; 28(16):2719-26. PubMed ID: 20421535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediagnostic circulating inflammation markers and endometrial cancer risk in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.
    Trabert B; Eldridge RC; Pfeiffer RM; Shiels MS; Kemp TJ; Guillemette C; Hartge P; Sherman ME; Brinton LA; Black A; Chaturvedi AK; Hildesheim A; Berndt SI; Safaeian M; Pinto L; Wentzensen N
    Int J Cancer; 2017 Feb; 140(3):600-610. PubMed ID: 27770434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.
    Trabert B; Pinto L; Hartge P; Kemp T; Black A; Sherman ME; Brinton LA; Pfeiffer RM; Shiels MS; Chaturvedi AK; Hildesheim A; Wentzensen N
    Gynecol Oncol; 2014 Nov; 135(2):297-304. PubMed ID: 25158036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory Cytokines and Lung Cancer Risk in 3 Prospective Studies.
    Brenner DR; Fanidi A; Grankvist K; Muller DC; Brennan P; Manjer J; Byrnes G; Hodge A; Severi G; Giles GG; Johansson M; Johansson M
    Am J Epidemiol; 2017 Jan; 185(2):86-95. PubMed ID: 27998891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating Biomarkers of Inflammation and Ovarian Cancer Risk in the Nurses' Health Studies.
    Peres LC; Townsend MK; Birmann BM; Conejo-Garcia JR; Kim Y; Kubzansky LD; Magpantay LI; Martinez-Maza O; Tworoger SS
    Cancer Epidemiol Biomarkers Prev; 2021 Apr; 30(4):710-718. PubMed ID: 33563649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating inflammation markers and risk of epithelial ovarian cancer.
    Clendenen TV; Lundin E; Zeleniuch-Jacquotte A; Koenig KL; Berrino F; Lukanova A; Lokshin AE; Idahl A; Ohlson N; Hallmans G; Krogh V; Sieri S; Muti P; Marrangoni A; Nolen BM; Liu M; Shore RE; Arslan AA
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):799-810. PubMed ID: 21467242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating inflammatory markers and colorectal cancer risk: A prospective case-cohort study in Japan.
    Song M; Sasazuki S; Camargo MC; Shimazu T; Charvat H; Yamaji T; Sawada N; Kemp TJ; Pfeiffer RM; Hildesheim A; Pinto LA; Rabkin CS; Tsugane S
    Int J Cancer; 2018 Dec; 143(11):2767-2776. PubMed ID: 30132835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDC and BLC are independently associated with the significant risk of early stage lung adenocarcinoma.
    Zhang Y; Yu K; Hu S; Lou Y; Liu C; Xu J; Li R; Zhang X; Wang H; Han B
    Oncotarget; 2016 Dec; 7(50):83051-83059. PubMed ID: 27811371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers.
    Toriola AT; Cheng TY; Neuhouser ML; Wener MH; Zheng Y; Brown E; Miller JW; Song X; Beresford SA; Gunter MJ; Caudill MA; Ulrich CM
    Int J Cancer; 2013 Jun; 132(11):2648-58. PubMed ID: 23161620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating high sensitivity C reactive protein concentrations and risk of lung cancer: nested case-control study within Lung Cancer Cohort Consortium.
    Muller DC; Larose TL; Hodge A; Guida F; Langhammer A; Grankvist K; Meyer K; Cai Q; Arslan AA; Zeleniuch-Jacquotte A; Albanes D; Giles GG; Sesso HD; Lee IM; Gaziano JM; Yuan JM; Hoffman Bolton J; Buring JE; Visvanathan K; Le Marchand L; Purdue MP; Caporaso NE; Midttun Ø; Ueland PM; Prentice RL; Weinstein SJ; Stevens VL; Zheng W; Blot WJ; Shu XO; Zhang X; Xiang YB; Koh WP; Hveem K; Thomson CA; Pettinger M; Engström G; Brunnström H; Milne RL; Stampfer MJ; Han J; Johansson M; Brennan P; Severi G; Johansson M
    BMJ; 2019 Jan; 364():k4981. PubMed ID: 30606716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine and Chemokine Concentration in the Tear of Patients with Age-Related Cataract.
    Engelbrecht C; Sardinha LR; Rizzo LV
    Curr Eye Res; 2020 Sep; 45(9):1101-1106. PubMed ID: 31928443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum C-reactive protein and risk of lung cancer: a case-control study.
    Xu M; Zhu M; Du Y; Yan B; Wang Q; Wang C; Zhao J
    Med Oncol; 2013 Mar; 30(1):319. PubMed ID: 23254959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between self-reported diabetes and 78 circulating markers of inflammation, immunity, and metabolism among adults in the United States.
    Van Dyke AL; Lang Kuhs KA; Shiels MS; Koshiol J; Trabert B; Loftfield E; Purdue MP; Wentzensen N; Pfeiffer RM; Katki HA; Hildesheim A; Kemp TJ; Pinto LA; Chaturvedi AK; Safaeian M
    PLoS One; 2017; 12(7):e0182359. PubMed ID: 28753646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort.
    Grote VA; Kaaks R; Nieters A; Tjønneland A; Halkjær J; Overvad K; Skjelbo Nielsen MR; Boutron-Ruault MC; Clavel-Chapelon F; Racine A; Teucher B; Becker S; Pischon T; Boeing H; Trichopoulou A; Cassapa C; Stratigakou V; Palli D; Krogh V; Tumino R; Vineis P; Panico S; Rodríguez L; Duell EJ; Sánchez MJ; Dorronsoro M; Navarro C; Gurrea AB; Siersema PD; Peeters PH; Ye W; Sund M; Lindkvist B; Johansen D; Khaw KT; Wareham N; Allen NE; Travis RC; Fedirko V; Jenab M; Michaud DS; Chuang SC; Romaguera D; Bueno-de-Mesquita HB; Rohrmann S
    Br J Cancer; 2012 May; 106(11):1866-74. PubMed ID: 22617158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study.
    Dossus L; Rinaldi S; Becker S; Lukanova A; Tjonneland A; Olsen A; Stegger J; Overvad K; Chabbert-Buffet N; Jimenez-Corona A; Clavel-Chapelon F; Rohrmann S; Teucher B; Boeing H; Schütze M; Trichopoulou A; Benetou V; Lagiou P; Palli D; Berrino F; Panico S; Tumino R; Sacerdote C; Redondo ML; Travier N; Sanchez MJ; Altzibar JM; Chirlaque MD; Ardanaz E; Bueno-de-Mesquita HB; van Duijnhoven FJ; Onland-Moret NC; Peeters PH; Hallmans G; Lundin E; Khaw KT; Wareham N; Allen N; Key TJ; Slimani N; Hainaut P; Romaguera D; Norat T; Riboli E; Kaaks R
    Endocr Relat Cancer; 2010 Dec; 17(4):1007-19. PubMed ID: 20843938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.